Squaring the circle: circRNAs in melanoma
- 30 July 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (37), 5559-5566
- https://doi.org/10.1038/s41388-021-01977-1
Abstract
Non-coding RNAs are emerging as critical molecules in the genesis, progression, and therapy resistance of cutaneous melanoma. This includes circular RNAs (circRNAs), a class of non-coding RNAs with distinct characteristics that forms through non-canonical back-splicing. In this review, we summarize the features and functions of circRNAs and introduce the current knowledge of the roles of circRNAs in melanoma. We also highlight the various mechanisms of action of the well-studied circRNA CDR1as and describe how it acts as a melanoma tumor suppressor. We further discuss the utility of circRNAs as biomarkers, therapeutic targets, and therapeutic agents in melanoma and outline challenges that must be overcome to comprehensively characterize circRNA functions.This publication has 100 references indexed in Scilit:
- Cell-Type Specific Features of Circular RNA ExpressionPLoS Genetics, 2013
- Signatures of mutational processes in human cancerNature, 2013
- MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growthJCI Insight, 2013
- Circular RNAs are abundant, conserved, and associated with ALU repeatsRNA, 2012
- Circular RNAs Are the Predominant Transcript Isoform from Hundreds of Human Genes in Diverse Cell TypesPLOS ONE, 2012
- Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence EvolutionCell, 2011
- miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNAThe EMBO Journal, 2011
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Targeted Nanoparticles Deliver siRNA to MelanomaJournal of Investigative Dermatology, 2010
- Circular transcripts of the testis-determining gene Sry in adult mouse testisCell, 1993